当前位置:首页 - 行情中心 - 鹿得医疗(920278) - 财务分析 - 现金流量表

鹿得医疗

(920278)

  

流通市值:5.51亿  总市值:9.75亿
流通股本:9864.53万   总股本:1.75亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金162,428,706.03126,863,096.5865,317,203.95422,418,666.16
  收到的税费返还24,567,716.4716,519,630.239,021,296.4630,016,289.87
  收到其他与经营活动有关的现金2,182,397.371,541,082.21,627,238.264,239,324.42
  经营活动现金流入小计189,178,819.87144,923,809.0175,965,738.67456,674,280.45
  购买商品、接受劳务支付的现金135,161,269.86106,229,550.348,932,211.49201,098,853.04
  支付给职工以及为职工支付的现金60,773,733.1341,857,072.0521,426,364.8174,738,861.24
  支付的各项税费4,815,077.463,336,741.71,648,924.929,451,394.69
  支付其他与经营活动有关的现金23,799,759.4817,876,468.9210,576,612.1918,210,825.41
  经营活动现金流出小计224,549,839.93169,299,832.9782,584,113.41303,499,934.38
  经营活动产生的现金流量净额-35,371,020.06-24,376,023.96-6,618,374.74153,174,346.07
二、投资活动产生的现金流量:
  收回投资收到的现金784,338,579.78773,338,579.78478,259,218.1801,451,487.66
  取得投资收益收到的现金904,249.92900,529.23391,903.774,189,043.49
  处置固定资产、无形资产和其他长期资产收回的现金净额4,7292,340--
  收到的其他与投资活动有关的现金-8,979,496.457,336,746.75,109,677.35
  投资活动现金流入小计785,247,558.7783,220,945.46485,987,868.57810,750,208.5
  购建固定资产、无形资产和其他长期资产支付的现金23,599,474.7418,726,162.1714,685,729.9143,217,448.44
  投资支付的现金782,008,335.32757,508,335.32427,331,741.75896,806,630
  支付其他与投资活动有关的现金-2,099,483.5--
  投资活动现金流出小计805,607,810.06778,333,980.99442,017,471.66940,024,078.44
  投资活动产生的现金流量净额-20,360,251.364,886,964.4743,970,396.91-129,273,869.94
三、筹资活动产生的现金流量:
  取得借款收到的现金48,000,00039,500,00029,500,00054,900,000
  收到其他与筹资活动有关的现金9,614,196.35--17,417.39
  筹资活动现金流入小计57,614,196.3539,500,00029,500,00054,917,417.39
  偿还债务支付的现金53,910,00043,910,00035,010,00030,790,000
  分配股利、利润或偿付利息支付的现金563,075.23412,161.07133,399.436,015,996.61
  支付其他与筹资活动有关的现金11,898,143.24900,000150,416.67450,000
  筹资活动现金流出小计66,371,218.4745,222,161.0735,293,816.0767,255,996.61
  筹资活动产生的现金流量净额-8,757,022.12-5,722,161.07-5,793,816.07-12,338,579.22
四、汇率变动对现金及现金等价物的影响-2,389,587.35-1,154,040.58-701,590.38-778,854.33
五、现金及现金等价物净增加额-66,877,880.89-26,365,261.1430,856,615.7210,783,042.58
  加:期初现金及现金等价物余额139,665,164.67139,665,164.67139,665,164.67128,882,122.09
  期末现金及现金等价物余额72,787,283.78113,299,903.53170,521,780.39139,665,164.67
补充资料:
  净利润-3,457,248.32-19,220,537
  资产减值准备-339,521.86--436,102.41
  固定资产和投资性房地产折旧-4,103,283.88-6,630,610.24
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-4,103,283.88-6,630,610.24
  无形资产摊销-493,412.06-575,036.08
  长期待摊费用摊销-91,622.32-244,509.22
  处置固定资产、无形资产和其他长期资产的损失---3,276.33
  固定资产报废损失-14,042.92--
  公允价值变动损失--1,089,981.49--440,882.65
  财务费用-1,777,769.19-2,650,452.08
  投资损失--2,785,539.38--2,843,824.45
  递延所得税--793,841.24--1,421.78
  其中:递延所得税资产减少--793,841.24--1,421.78
  存货的减少--4,759,793.5-4,241,545.78
  经营性应收项目的减少-5,119,582.69-59,383,074.8
  经营性应付项目的增加--30,906,332.93-65,419,290.07
  现金的期末余额-113,299,903.53-139,665,164.67
  减:现金的期初余额-139,665,164.67-128,882,122.09
  现金及现金等价物的净增加额--26,365,261.14-10,783,042.58
公告日期2026-10-292026-08-252026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑